MYD88 and pulmonary fibrosis: Li et al. [18] used PC to treat mice that had bleomycin-induced pulmonary fibrosis, and found that PC could pass through the TLR2-MyD88-NF-κB signaling pathway to effectively inhibit the bleomycin-induced pulmonary fibrosis.